| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.009 |